Search

Your search keyword '"Luescher I"' showing total 125 results

Search Constraints

Start Over You searched for: Author "Luescher I" Remove constraint Author: "Luescher I"
125 results on '"Luescher I"'

Search Results

2. CD8 T cell function and cross-reactivity explored by stepwise increased peptide-HLA versus TCR affinity

Catalog

Books, media, physical & digital resources

4. Further Analysis of the Role of MHC Molecules in Antigen Presentation

6. The Efficiency of Antigen Recognition by CD8+ CTL Clones Is Determined by the Frequency of Serial TCR Engagement

7. Analysis, Isolation, and Activation of Antigen-Specific CD4 + and CD8+ T Cells by Soluble MHC-Peptide Complexes

11. A peptide encoded by human gene MAGE-3 and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3.

25. T cell recognition of hapten. Anatomy of T cell receptor binding of a H-2kd-associated photoreactive peptide derivative.

26. Differential roles of T cell receptor alpha and beta chains in ligand binding among H-2Kd-restricted cytolytic T lymphocyte clones specific for a photoreactive Plasmodium berghei circumsporozoite peptide derivative.

27. Binding of photoreactive lysozyme peptides to murine histocompatibility class II molecules.

28. HLA photoaffinity labeling reveals overlapping binding of homologous melanoma-associated gene peptides by HLA-A1, HLA-A29, and HLA-B44.

31. Peptide modification or blocking of CD8, resulting in weak TCR signaling, can activate CTL for Fas- but not perforin-dependent cytotoxicity or cytokine production

32. Highly diverse T cell recognition of a single Plasmodium berghei peptide presented by a series of mutant H-2K(d) molecules

33. Immunization with synthetic peptides containing a defined malaria epitope induces a highly diverse cytotoxic t lymphocyte response: Evidence that two peptide residues are buried in the MHC molecule

40. Probing the Conformational Dynamics of Affinity-Enhanced T Cell Receptor Variants upon Binding the Peptide-Bound Major Histocompatibility Complex by Hydrogen/Deuterium Exchange Mass Spectrometry.

41. The T-Cell Receptor Can Bind to the Peptide-Bound Major Histocompatibility Complex and Uncomplexed β 2 -Microglobulin through Distinct Binding Sites.

42. In silico and cell-based analyses reveal strong divergence between prediction and observation of T-cell-recognized tumor antigen T-cell epitopes.

43. Vaccination with LAG-3Ig (IMP321) and Peptides Induces Specific CD4 and CD8 T-Cell Responses in Metastatic Melanoma Patients--Report of a Phase I/IIa Clinical Trial.

44. Identification of Rare High-Avidity, Tumor-Reactive CD8+ T Cells by Monomeric TCR-Ligand Off-Rates Measurements on Living Cells.

45. Nonclassical antigen-processing pathways are required for MHC class II-restricted direct tumor recognition by NY-ESO-1-specific CD4(+) T cells.

46. Analysis, Isolation, and Activation of Antigen-Specific CD4(+) and CD8(+) T Cells by Soluble MHC-Peptide Complexes.

47. T cells maintain an exhausted phenotype after antigen withdrawal and population reexpansion.

48. Establishment of animal models to analyze the kinetics and distribution of human tumor antigen-specific CD8⁺ T cells.

49. MHC class II/ESO tetramer-based generation of in vitro primed anti-tumor T-helper lines for adoptive cell therapy of cancer.

50. Induction of CD8 T-cell responses restricted to multiple HLA class I alleles in a cancer patient by immunization with a 20-mer NY-ESO-1f (NY-ESO-1 91-110) peptide.